Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,794 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Panta rhei, also drug eluting stent technology.
Chiarito M, Mehran R. Chiarito M, et al. Among authors: mehran r. Catheter Cardiovasc Interv. 2020 May 1;95(6):1074-1075. doi: 10.1002/ccd.28918. Catheter Cardiovasc Interv. 2020. PMID: 32421244
Coronary artery stenting.
Ashby DT, Dangas G, Mehran R, Leon MB. Ashby DT, et al. Among authors: mehran r. Catheter Cardiovasc Interv. 2002 May;56(1):83-102. doi: 10.1002/ccd.10209. Catheter Cardiovasc Interv. 2002. PMID: 11979540 Review. No abstract available.
Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restenosis model.
Kipshidze NN, Iversen P, Kim HS, Yiazdi H, Dangas G, Seaborn R, New G, Tio F, Waksman R, Mehran R, Tsapenko M, Stone GW, Roubin GS, Iyer S, Leon MB, Moses JW. Kipshidze NN, et al. Among authors: mehran r. Catheter Cardiovasc Interv. 2004 Apr;61(4):518-27. doi: 10.1002/ccd.20007. Catheter Cardiovasc Interv. 2004. PMID: 15065150
Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial).
Costa RA, Lansky AJ, Mintz GS, Mehran R, Tsuchiya Y, Negoita M, Gilutz Y, Nikolsky E, Fahy M, Pop R, Cristea E, Carlier S, Dangas G, Stone GW, Leon MB, Müller R, Techen G, Grube E. Costa RA, et al. Among authors: mehran r. Am J Cardiol. 2005 Jan 1;95(1):113-6. doi: 10.1016/j.amjcard.2004.08.074. Am J Cardiol. 2005. PMID: 15619406 Clinical Trial.
Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials).
Tsuchiya Y, Lansky AJ, Costa RA, Mehran R, Pietras C, Shimada Y, Sonoda S, Cristea E, Negoita M, Dangas GD, Moses JW, Leon MB, Fitzgerald PJ, Müller R, Störger H, Hauptmann KE, Grube E. Tsuchiya Y, et al. Among authors: mehran r. Am J Cardiol. 2006 Aug 15;98(4):464-9. doi: 10.1016/j.amjcard.2006.02.054. Epub 2006 Jun 19. Am J Cardiol. 2006. PMID: 16893698 Clinical Trial.
Randomized, double-blind, multicenter study of the polymer-based 17-beta estradiol-eluting stent for treatment of native coronary artery lesions: six-month results of the ETHOS I trial.
Abizaid A, Chaves AJ, Leon MB, Hauptmann K, Mehran R, Lansky AJ, Baumbach W, Shankar H, Muller R, Feres F, Sousa AG, Sousa JE, Grube E. Abizaid A, et al. Among authors: mehran r. Catheter Cardiovasc Interv. 2007 Nov 1;70(5):654-60. doi: 10.1002/ccd.21210. Catheter Cardiovasc Interv. 2007. PMID: 17932898 Clinical Trial.
1,794 results